Navigation Links
Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia

ther than 16, suggesting cross-reactivity.

In a second presentation of data from the same cohort of 58 evaluable patients, CD4 and CD8 positive T cells were activated with pooled E6 and E7 peptides and tested for interferon gamma production and degranulation. Blinded histologic sections of the final cervical conization specimens were independently graded for inflammation using a standardized protocol (0 no inflammation and 4 the highest level of inflammation.). There was significantly more cervical inflammation in patients who did not undergo regression after HspE7 immunotherapy. Local inflammation did not correlate with type-specific HPV infection or systemic T cell responses to HPV peptides; however, this study may have been underpowered to predict these observations in this subset of women with heterogeneous T cell responses. Further studies are currently underway.

About HspE7, Lead Product Candidate:

------------------------------------

HspE7 is a novel therapeutic vaccine candidate for the treatment of diseases caused by the human papillomavirus (HPV), one of the most common sexually transmitted diseases in the world. HspE7 is derived from Nventa's proprietary CoVal(TM) fusion platform, which uses recombinant DNA technology to covalently fuse stress proteins to target antigens, thereby stimulating cellular immune system responses. Stress proteins, also known as heat shock proteins (Hsps), are naturally present in the human body and play important roles in the immune system, including transporting substances within cells and activating cells of the immune system. Nventa is pursuing clinical development of HspE7 in combination with an adjuvant.

About Nventa Corporation:

-------------------------

Nventa is developing innovative therapeutics for the treatment of viral infections and cancer, with a focus on diseases caused by the human papillomavirus (HPV). The corporation is publicly traded on the Toronto Stock Excha
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:7/25/2014)... 2014  In today,s marketplace, launching multiple products for ... as is managing a portfolio of products in the ... - or even preferable - to pool resources to ... combine resources and activities, and what marketing and sales ... just a few of the dilemmas facing pharmaceutical sales, ...
(Date:7/25/2014)... MISSION, Kan. , July 25, 2014 /PRNewswire-iReach/ ... , and TCGRx, of Powers Lake, ... exclusive partners in a distribution and co-marketing agreement ... to retail pharmacies throughout the United ... of robotics-based pharmacy management and workflow systems to ...
(Date:7/25/2014)... , July 25, 2014  The Chemistry, ... Tobago Ministry of Health approved the introduction of ... increases the cure rate from Hepatitis C, and ... genotype 1 virus. Telaprevir is available in ... INCIVO®. Photo - http://www2.prnewswire.com.br/imgs/pub/2014-07-25/original/2026.jpg   ...
Breaking Medicine Technology:Using Promotional Efficiency to Support Multiple Products and Indications in the Pharmaceutical Marketplace 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3
... and INGELHEIM, Germany, July 6, 2011 As part ... the most promising solutions to challenging health problems around ... the launch of the Making More Health: Achieving ... This worldwide competition invites the most ...
... Inc. (NYSE: RMD and ASX: ... medical equipment for treating, diagnosing and managing sleep-disordered ... it has acquired BiancaMed Ltd., a leading Irish ... outstanding shares with cash.   (Logo: ...
Cached Medicine Technology:Boehringer Ingelheim and Ashoka's Changemakers Launch "Making More Health" Competition 2Boehringer Ingelheim and Ashoka's Changemakers Launch "Making More Health" Competition 3ResMed Announces Acquisition of BiancaMed 2ResMed Announces Acquisition of BiancaMed 3
(Date:7/28/2014)... HealthDay Reporter FRIDAY, July 25, ... policy that bans blood donations from gay and bisexual men, according ... in the Journal of the American Medical Association . ... cannot donate blood in the United States -- a lifetime ban ... and Drug Administration adopted this policy at the dawn of the ...
(Date:7/28/2014)... a healthy lifestyle may help childhood cancer survivors reduce ... indicates. Researchers suggested that children with cancer and ... about how their diet and certain behaviors could ... are important because they indicate that adults who were ... influence their own health outcomes," said one of the ...
(Date:7/28/2014)... "We experienced difficulty filling our pill ... two inventors from Jamestown, Calif. "We came up with ... we could pour medications in more easily." , They ... keep the lids open as the pill box is ... compartments have been filled. This eliminates hassles and frustrations, ...
(Date:7/28/2014)... 28, 2014 Scientists in Japan have ... improved blood test for the asbestos cancer mesothelioma. Surviving ... research. Click here to read it now. ... Tokyo’s Juntendo University Graduate School of Medicine say a ... a step above the old test. , “Particularly ...
(Date:7/28/2014)... Hill, South Carolina (PRWEB) July 28, 2014 ... people enjoy their first bite of food best, with ... before. Over-indulging, the researchers found, can actually serve to ... to overindulge in foods they enjoy, not realizing the ... statement. "This is the argument for moderation, if we ...
Breaking Medicine News(10 mins):Health News:Lift U.S. Ban on Blood Donations by Gay Men, Experts Say 2Health News:Lift U.S. Ban on Blood Donations by Gay Men, Experts Say 3Health News:Healthy Habits May Help Childhood Cancer Survivors Avoid Chronic Ills 2Health News:Test Results Look Promising for New Mesothelioma Blood Test, According to Surviving Mesothelioma 2Health News:Large Portions Can Decrease Food Enjoyment, SlimPlate Weight Loss System Puts Focus On Portion Control 2Health News:Large Portions Can Decrease Food Enjoyment, SlimPlate Weight Loss System Puts Focus On Portion Control 3
... MIAMI, Oct. 8 Infants and toddlers cannot ... on over-the-counter children,s,medicines, parents need a safe alternative ... been the bulb aspirator. However, these can,irritate a ... In-the-know parents have discovered the safe, effective alternative,that,s ...
... treatment for breast cancer differs between African-American women and ... insurance type. The study appears in the November 15, ... American Cancer Society. , Dr. Mousumi Banerjee of ... from Wayne State University and Dr. William Hryniuk from ...
... progression of age-related macular degeneration (AMD), according to a ... Human Nutrition Research Center on Aging at Tufts University. ... in 7 to 15% of the elderly, according to ... be the most practical and cost-effective prevention method to ...
... BEND, Ind., Oct. 7 OCS, Inc. and,Press ... into a,partnership, whereby the companies have combined their ... of products for the home,health care industry. The ... analysis of interrelated performance metrics integrating,patient satisfaction, patient ...
... The following is a,transcript of a radio address by ... morning., One important commitment of the Federal government ... care. Most of these children are,covered by Medicaid, which ... fiscal year. For children who do not qualify for ...
... Studies link this common problem with vascular disease , , ... realize it, but if they,re having problems achieving or ... Erectile dysfunction, or impotence, affects more than 18 million ... at the Johns Hopkins Bloomberg School of Public Health. ...
Cached Medicine News:Health News:As Cold & Flu Season Nears, New Baby Nasal Aspirator Offers Safe and Effective Alternative to FDA-Discouraged Medicines 2Health News:Differences observed between black and white women in use of breast cancer therapy 2Health News:Limiting refined carbohydrates may stall AMD progression 2Health News:OCS and Press Ganey Partner to Create Joint Analysis of Outcomes and Satisfaction 2Health News:Radio Address by President Bush to the Nation 2Health News:Erectile Dysfunction: A Harbinger of Heart Trouble 2Health News:Erectile Dysfunction: A Harbinger of Heart Trouble 3
The Achieva CV brings the power of CMR into routine clinical practice, so you can do more in Cardiovascular MR....
The Clearblue Easy Digital Ovulation Test detects the surge of "luteinizing hormone in your urine, which usually happens 24 to 36 hours before you ovulate (release an egg). That means youll know the...
These products are primarily for use with paediatric patients and for patients with difficult veins....
Paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Medicine Products: